Ideal Cures to launch new tablet coating product in Geneva
New Delhi, May 21 : Indian pharmaceutical company Ideal Cures will launch Instanute DR, a coating product for solid oral medicines at the Vitafoods Europe event in Geneva Tuesday.
"Instanute DR is a path-breaking product for delaying the release of the active ingredients having wide applicability in nutraceutical, food and dietary supplement industry," Suresh Pareek, managing director and one of the inventors of the product, said in a statement.
"Instanute DR is ready to use enteric coating product and will help in maintaining efficacy of the active ingredient which are sensitive to high acidic pH in stomach," he added.
Instanute DR is a film that is applied by a coating process to postpone the release of active ingredients in the intestine.
Through its use, scientists will be able to programme the release profile of the active ingredients ranging from 20 to 120 minutes. This is the first time Alginic Acid- based composition has been developed to delay the release of drugs by film coating.
Ideal Cures is the world's leading manufacturer and exporter of pharmaceutical excipients, acrylic polymers and ready-to-use coating systems for solid oral dosage forms. It has three manufacturing plants located at Vasai, Jammu and Khambhat along with two modern research and development facilities at Mumbai and Vasai.